Pulmatrix, Inc. (PULM): Net Income
-$5.16M
Year ended 2025-12-31
-$4.01M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$5.16M | n/m | 2026-06-16, From 2025-01-01 |
| 2024-12-31 | -$9.56M | n/m | 2026-06-16, From 2024-01-01 |
| 2023-12-31 | -$14.12M | n/m | 2025-03-21, From 2023-01-01 |
| 2022-12-31 | -$18.84M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$20.17M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$19.31M | n/m | 2022-03-29, From 2020-01-01 |
| 2019-12-31 | -$20.60M | n/m | 2021-03-23, From 2019-01-01 |
| 2018-12-31 | -$20.56M | n/m | 2020-03-26, From 2018-01-01 |
| 2017-12-31 | -$18.06M | n/m | 2019-02-19, From 2017-01-01 |
| 2016-12-31 | -$27.84M | n/m | 2018-03-13, From 2016-01-01 |
| 2015-12-31 | -$26.17M | n/m | 2017-03-10, From 2015-01-01 |
| 2014-12-31 | -$24.14M | n/a | 2016-03-10, From 2014-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | 2025-12-31 | -$5.16M | n/m |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | -$11.90M | n/m |
| Cadrenal Therapeutics, Inc. (CVKD) | 2025-12-31 | -$13.24M | n/m |
| Bio-Path Holdings, Inc. (BPTH) | 2024-12-31 | -$9.89M | n/m |
| Protagenic Therapeutics, Inc.\new (PTIX) | 2026-03-31 | $1.37M | n/m |
| International Stem Cell Corp (ISCO) | 2025-12-31 | -$418.0K | n/m |
| Azitra, Inc. (AZTR) | 2025-12-31 | -$10.96M | n/m |
| Enveric Biosciences, Inc. (ENVB) | 2025-12-31 | -$8.77M | n/m |
| Petros Pharmaceuticals, Inc. (PTPI) | 2025-12-31 | $1.91M | n/m |
Compare PULM, LEXX, CVKD, BPTH side by side · Screen every company in Pharmaceutical Preparations ↗